Nature
The cover illustrates that a peptide identified via screening aids the delivery of CRISPR ribonucleoprotein into cells, increasing the yield of edited primary human lymphocytes.
Peptide-boosted uptake of CRISPR enzymes
The yields of edited primary human lymphocytes can be increased substantially, with respect to those obtained via electroporation, by delivering a CRISPR ribonucleoprotein alongside an amphiphilic peptide identified via screening.
Published
Chief Editor, Nature Biomedical Engineering, Nature Research
-
Nature Biomedical Engineering
This journal aspires to become the most prominent publishing venue in biomedical engineering by bringing together the most important advances in the discipline, enhancing their visibility, and providing overviews of the state of the art in each field.
Please sign in or register for FREE
If you are a registered user on Nature Portfolio Bioengineering Community, please sign in